Complete response for advanced liver cancer during sorafenib therapy: Case Report

BACKGROUND: Hepatocellular carcinoma (HCC) is the fifth most common neoplasia in the world. In the past, treatment of advanced HCC with conventional antineoplastic drugs did not result in satisfactory outcomes: recently, in this patient population the oral multikinase inhibitor sorafenib has been ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacco, Rodolfo, Bargellini, Irene, Gianluigi, Giannelli, Bertini, Marco, Bozzi, Elena, Altomare, Emanuele, Battaglia, Valentina, Romano, Antonio, Bertoni, Michele, Capria, Alfonso, Bresci, Giampaolo, Bartolozzi, Carlo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036648/
https://www.ncbi.nlm.nih.gov/pubmed/21241463
http://dx.doi.org/10.1186/1471-230X-11-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036648/
https://www.ncbi.nlm.nih.gov/pubmed/21241463
http://dx.doi.org/10.1186/1471-230X-11-4

Ejemplares similares